AnPac Bio-Medical Science Co., Ltd. (ANPC:NASDAQ) rocketted at $0.34, a gain of 37.9%. On Wed, Aug 24, 2022, ANPC:NASDAQ touched a New 2-Week Intraday High of $0.36. From Wed, Aug 10, 2022, the stock recorded 30.00% Up Days and 18.18% Green Days
The stock spiked on Mon, Aug 22, 2022 at $0.59 with a volume of 98M+.
About AnPac Bio-Medical Science Co., Ltd. (ANPC:NASDAQ)
AnPac Bio-Medical Science Co Ltd is a biotechnology company. It focuses on early cancer screening and detection. The company markets and sells a multi-cancer screening and detection test that uses its innovative, patented CDA technology and its proprietary CDA device. In addition to early cancer screening and detection, its CDA technology has demonstrated potential to assist physicians in cancer diagnosis, prognosis and recurrence.
Top 10 Gainers:
- Minerva Neurosciences, Inc. (NERV:NASDAQ), 66.52%
- SuperCom Ltd. (SPCB:NASDAQ), 62.36%
- Bright Minds Biosciences Inc. (DRUG:NASDAQ), 48.87%
- Social Capital Suvretta Holdings Corp. I (DNAA:NASDAQ), 48.26%
- AnPac Bio-Medical Science Co., Ltd. (ANPC:NASDAQ), 37.9%
- Riverview Acquisition Corp. (RVAC:NASDAQ), 34.86%
- Gravitas Education Holdings Inc ADR (GEHI:NYSE), 24.83%
- Turquoise Hill Resources Ltd. (TRQ:NYSE), 23.76%
- Golden Sun Education Group Limited (GSUN:NASDAQ), 22.83%
- Farfetch Limited (FTCH:NYSE), 21.3%